Eriko Goto

1.2k total citations
23 papers, 920 citations indexed

About

Eriko Goto is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Eriko Goto has authored 23 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 19 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Eriko Goto's work include Liver Disease Diagnosis and Treatment (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Eriko Goto is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Eriko Goto collaborates with scholars based in Japan, United States and Switzerland. Eriko Goto's co-authors include Ryosuke Tateishi, Ryota Masuzaki, Haruhiko Yoshida, Tadashi Goto, Shuichiro Shiina, Masao Omata, Takamasa Ohki, Takahisa Sato, Fumihiko Kanai and Hitoshi Ikeda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Eriko Goto

21 papers receiving 899 citations

Peers

Eriko Goto
Eriko Goto
Citations per year, relative to Eriko Goto Eriko Goto (= 1×) peers Jean Claude Trinchet

Countries citing papers authored by Eriko Goto

Since Specialization
Citations

This map shows the geographic impact of Eriko Goto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eriko Goto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eriko Goto more than expected).

Fields of papers citing papers by Eriko Goto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eriko Goto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eriko Goto. The network helps show where Eriko Goto may publish in the future.

Co-authorship network of co-authors of Eriko Goto

This figure shows the co-authorship network connecting the top 25 collaborators of Eriko Goto. A scholar is included among the top collaborators of Eriko Goto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eriko Goto. Eriko Goto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ohki, Takamasa, Mayuko Kondo, Koki Sato, et al.. (2021). Atezolizumab plus bevacizumab as a second-line treatment after lenvatinib failure. Kanzo. 62(9). 585–587. 1 indexed citations
2.
Ohki, Takamasa, Koki Sato, Mayuko Kondo, et al.. (2020). Impact of Adverse Events on the Progression-Free Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Retrospective Study. Drugs - Real World Outcomes. 7(2). 141–149. 28 indexed citations
3.
Ohki, Takamasa, Koki Sato, Mayuko Kondo, et al.. (2020). Relationship between outcomes and relative dose intensity of lenvatinib treatment in patients with advanced hepatocellular carcinoma. Liver Research. 4(4). 199–205. 5 indexed citations
4.
Abe, Michiko, Kazuhiro Watanabe, Shunsuke Watanabe, et al.. (2013). Poorly differentiated neuroendocrine carcinoma (PDNEC) of the sigmoid colon, primary advanced diffuse infiltrative type. Progress of Digestive Endoscopy. 83(1). 148–149.
5.
Uchino, Koji, Shuntaro Obi, Ryosuke Tateishi, et al.. (2012). Systemic combination therapy of intravenous continuous 5-fluorouracil and subcutaneous pegylated interferon alfa-2a for advanced hepatocellular carcinoma. Journal of Gastroenterology. 47(10). 1152–1159. 10 indexed citations
6.
Goto, Eriko, Ryota Masuzaki, Ryosuke Tateishi, et al.. (2011). Value of post-vascular phase (Kupffer imaging) by contrast-enhanced ultrasonography using Sonazoid in the detection of hepatocellular carcinoma. Journal of Gastroenterology. 47(4). 477–485. 45 indexed citations
7.
Goto, Tadashi, Haruhiko Yoshida, Ryosuke Tateishi, et al.. (2011). Influence of serum HBV DNA load on recurrence of hepatocellular carcinoma after treatment with percutaneous radiofrequency ablation. Hepatology International. 5(3). 767–773. 22 indexed citations
8.
Ohki, Takamasa, Ryosuke Tateishi, Masaaki Akahane, et al.. (2011). Characteristics of hepatocellular carcinoma nodules newly detected by computed tomography during arteriography and arterial portography: preliminary report of a randomized controlled trial. Hepatology International. 6(3). 639–645. 5 indexed citations
9.
Arano, Toru, Hayato Nakagawa, Ryosuke Tateishi, et al.. (2010). Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. International Journal of Cancer. 129(9). 2226–2235. 73 indexed citations
10.
Goto, Eriko, Ryosuke Tateishi, Shuichiro Shiina, et al.. (2010). Hemorrhagic Complications of Percutaneous Radiofrequency Ablation for Liver Tumors. Journal of Clinical Gastroenterology. 44(5). 374–380. 47 indexed citations
11.
Masuzaki, Ryota, Shuichiro Shiina, Ryosuke Tateishi, et al.. (2010). Utility of contrast‐enhanced ultrasonography with Sonazoid in radiofrequency ablation for hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 26(4). 759–764. 76 indexed citations
12.
Kondo, Yuji, Shuichiro Shiina, Ryosuke Tateishi, et al.. (2010). Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis. Liver International. 31(2). 197–205. 23 indexed citations
13.
Ohki, Takamasa, Ryosuke Tateishi, Eriko Goto, et al.. (2009). Influence of anti-HBc seropositivity on the risk of hepatocellular carcinoma in HCV-infected patients after adjusting for confounding factors. Journal of Viral Hepatitis. 17(2). 91–97. 10 indexed citations
14.
Masuzaki, Ryota, Ryosuke Tateishi, Haruhiko Yoshida, et al.. (2009). Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography†. Hepatology. 49(6). 1954–1961. 305 indexed citations
15.
Ohki, Takamasa, Ryosuke Tateishi, Eriko Goto, et al.. (2009). Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut. 58(6). 839–844. 109 indexed citations
16.
Sugioka, Yosuke, Eriko Goto, Atsushi Suzuki, et al.. (2009). 1131: Utility of Contrast Enhanced Ultrasonography with Sonazoid in Radiofrequency Ablation (RFA) for Liver Metastasis. Ultrasound in Medicine & Biology. 35(8). S134–S134.
17.
Tateishi, Ryosuke, Shuichiro Shiina, Takamasa Ohki, et al.. (2009). Treatment strategy for hepatocellular carcinoma: expanding the indications for radiofrequency ablation. Journal of Gastroenterology. 44(S19). 142–146. 16 indexed citations
18.
Imamura, Jun, Ryosuke Tateishi, Shuichiro Shiina, et al.. (2008). Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma. The American Journal of Gastroenterology. 103(12). 3057–3062. 81 indexed citations
19.
Masuzaki, Ryota, Ryosuke Tateishi, Haruhiko Yoshida, et al.. (2008). Comparison of Liver Biopsy and Transient Elastography based on Clinical Relevance. SHILAP Revista de lepidopterología. 22(9). 753–757. 21 indexed citations
20.
Yoshida, Hideo, Haruhiko Yoshida, Eriko Goto, et al.. (2007). Safety and efficacy of lamivudine after radiofrequency ablation in patients with hepatitis B virus-related hepatocellular carcinoma. Hepatology International. 2(1). 89–94. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026